|
| 36534496 | Metastatic Colorectal Cancer Treatment Response Evaluation by Ultra-Deep Sequencing of Cell-Free DNA and Matched White Blood Cells. | Clin Cancer Res | 2023 |
| 37719698 | Exploring novel genetic and hematological predictors of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. | Front Genet | 2023 |
| 38067353 | Identifying Genetic Mutation Status in Patients with Colorectal Cancer Liver Metastases Using Radiomics-Based Machine-Learning Models. | Cancers (Basel) | 2023 |
| 37895091 | Data-Independent Acquisition Mass Spectrometry Analysis of FFPE Rectal Cancer Samples Offers In-Depth Proteomics Characterization of the Response to Neoadjuvant Chemoradiotherapy. | Int J Mol Sci | 2023 |
| 38060377 | A scenario-drafting study to explore potential future implementation pathways of circulating tumor DNA testing in oncology. | Mol Oncol | 2023 |
| 37921412 | Risk Prediction of Metachronous Colorectal Cancer from Molecular Features of Adenomas: A Nested Case-Control Study. | Cancer Res Commun | 2023 |
| 37321815 | Towards Response ADAptive Radiotherapy for organ preservation for intermediate-risk rectal cancer (preRADAR): protocol of a phase I dose-escalation trial. | BMJ Open | 2023 |
| 37067589 | Comparison of NTRK fusion detection methods in microsatellite-instability-high metastatic colorectal cancer. | Virchows Arch | 2023 |
| 36655278 | Predicting early extrahepatic recurrence after local treatment of colorectal liver metastases. | Br J Surg | 2023 |
| 36402278 | A Micro-Costing Framework for Circulating Tumor DNA Testing in Dutch Clinical Practice. | J Mol Diagn | 2023 |
| 35148171 | Genome Nexus: A Comprehensive Resource for the Annotation and Interpretation of Genomic Variants in Cancer. | JCO Clin Cancer Inform | 2022 |
| 35842496 | High expression of secretory leukocyte protease inhibitor (SLPI) in stage III micro-satellite stable colorectal cancer is associated with reduced disease recurrence. | Sci Rep | 2022 |
| 35344447 | Reply to R. Pham et al. | JCO Precis Oncol | 2022 |
| 35396392 | CRISPRs in the human genome are differentially expressed between malignant and normal adjacent to tumor tissue. | Commun Biol | 2022 |
| 35395779 | KCNQ1 and lymphovascular invasion are key features in a prognostic classifier for stage II and III colon cancer. | BMC Cancer | 2022 |
| 35625968 | External Validation of Two Established Clinical Risk Scores Predicting Outcome after Local Treatment of Colorectal Liver Metastases in a Nationwide Cohort. | Cancers (Basel) | 2022 |
| 35565347 | Cell-Free Circulating (Tumor) DNA before Surgery as a Prognostic Factor in Non-Metastatic Colorectal Cancer: A Systematic Review. | Cancers (Basel) | 2022 |
| 35872559 | Overexpression of the miR-17-92 cluster in colorectal adenoma organoids causes a carcinoma-like gene expression signature. | Neoplasia | 2022 |
| 36334560 | Tumour break load is a biologically relevant feature of genomic instability with prognostic value in colorectal cancer. | Eur J Cancer | 2022 |
| 35255321 | Diagnostic performance of MRI for staging peritoneal metastases in patients with colorectal cancer after neoadjuvant chemotherapy. | Eur J Radiol | 2022 |
| 33341450 | Quantitative analysis of CDX2 protein expression improves its clinical utility as a prognostic biomarker in stage II and III colon cancer. | Eur J Cancer | 2021 |
| 33785492 | First-line palliative systemic therapy alternated with electrostatic pressurised intraperitoneal aerosol chemotherapy (oxaliplatin) for isolated unresectable colorectal peritoneal metastases: protocol of a multicentre, single-arm, phase II study (CRC-PIPAC-II). | BMJ Open | 2021 |
| 33587312 | Lipopolysaccharide-regulated secretion of soluble and vesicle-based proteins from a panel of colorectal cancer cell lines. | Proteomics Clin Appl | 2021 |
| 33890711 | Loss of enteric neuronal Ndrg4 promotes colorectal cancer via increased release of Nid1 and Fbln2. | EMBO Rep | 2021 |
| 33635598 | Detection of tumor-derived cell-free DNA from colorectal cancer peritoneal metastases in plasma and peritoneal fluid. | J Pathol Clin Res | 2021 |
| 34891161 | Fusion transcripts and their genomic breakpoints in polyadenylated and ribosomal RNA-minus RNA sequencing data. | Gigascience | 2021 |
| 34820593 | <i>KRAS</i> A146 Mutations Are Associated With Distinct Clinical Behavior in Patients With Colorectal Liver Metastases. | JCO Precis Oncol | 2021 |
| 34417454 | Detection and characterization of lung cancer using cell-free DNA fragmentomes. | Nat Commun | 2021 |
| 34009291 | Perioperative Systemic Therapy vs Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Alone for Resectable Colorectal Peritoneal Metastases: A Phase 2 Randomized Clinical Trial. | JAMA Surg | 2021 |
| 34333237 | Postoperative circulating tumour DNA is associated with pathologic response and recurrence-free survival after resection of colorectal cancer liver metastases. | EBioMedicine | 2021 |
| 34280333 | Clinical Validation of a Multitarget Fecal Immunochemical Test for Colorectal Cancer Screening : A Diagnostic Test Accuracy Study. | Ann Intern Med | 2021 |
| 31411736 | Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progression. | Int J Cancer | 2020 |
| 31784980 | Proteins in stool as biomarkers for non-invasive detection of colorectal adenomas with high risk of progression. | J Pathol | 2020 |
| 31988276 | White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer. | Nat Commun | 2020 |
| 33101778 | Expression of the immune modulator secretory leukocyte protease inhibitor (SLPI) in colorectal cancer liver metastases and matched primary tumors is associated with a poorer prognosis. | Oncoimmunology | 2020 |
| 32415199 | Performance of four platforms for KRAS mutation detection in plasma cell-free DNA: ddPCR, Idylla, COBAS z480 and BEAMing. | Sci Rep | 2020 |
| 32545483 | Silencing Core Spliceosome Sm Gene Expression Induces a Cytotoxic Splicing Switch in the Proteasome Subunit Beta 3 mRNA in Non-Small Cell Lung Cancer Cells. | Int J Mol Sci | 2020 |
| 32458162 | Modeling Personalized Adjuvant TreaTment in EaRly stage coloN cancer (PATTERN). | Eur J Health Econ | 2020 |
| 31023318 | Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6) | BMC Cancer | 2019 |
| 31352425 | Repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy (ePIPAC) with oxaliplatin as a palliative monotherapy for isolated unresectable colorectal peritoneal metastases: protocol of a Dutch, multicentre, open-label, single-arm, phase II study (CRC-PIPAC). | BMJ Open | 2019 |
| 31420015 | Prognostic value of microvessel density in stage II and III colon cancer patients: a retrospective cohort study. | BMC Gastroenterol | 2019 |
| 31189073 | Circulating biomarkers for early detection and clinical management of colorectal cancer. | Mol Aspects Med | 2019 |
| 30735634 | Widespread and Functional RNA Circularization in Localized Prostate Cancer. | Cell | 2019 |
| 31142840 | Genome-wide cell-free DNA fragmentation in patients with cancer. | Nature | 2019 |
| 29341165 | Histopathological and molecular classification of colorectal cancer and corresponding peritoneal metastases. | Br J Surg | 2018 |
| 29968252 | Consensus molecular subtype classification of colorectal adenomas. | J Pathol | 2018 |
| 30034629 | MACROD2 expression predicts response to 5-FU-based chemotherapy in stage III colon cancer. | Oncotarget | 2018 |
| 29685877 | Evaluation of Cancer-Associated DNA Copy Number Events in Colorectal (Advanced) Adenomas. | Cancer Prev Res (Phila) | 2018 |
| 29760449 | Aurora kinase A (AURKA) interaction with Wnt and Ras-MAPK signalling pathways in colorectal cancer. | Sci Rep | 2018 |
| 28747380 | Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify. | Mol Cell Proteomics | 2017 |